December 28, 1992, marked a new era for Migraine and cluster headaches sufferers when the FDA approved the first of a class of medications that many would come to call "miracle drugs." That drug was the injectable form of sumatriptan (Imitrex®, Imigran®), the first of the triptans. Now, the FDA has approved a new Imitrex® STATdose in a 4mg dosage. This is the same STATdose injection system patients have been using; only the dosage has changed. The 4mg STATdose provides a new option to patients for whom the 6mg was "too strong" or may have produced uncomfortable side effects. Feature article.